Table 1 Histopathology, stage, and age of included case patients
From: The prevalence of EBV and CMV DNA in epithelial ovarian cancer
EOC included N = 198 | |
|---|---|
Age, median (range) | 64 (58) |
FIGO Tumor stage | |
Stage I, n (%) | 31 (15.7%) |
Stage II, n (%) | 21 (10.6%) |
Stage III, n (%) | 120 (60.1%) |
Stage IV, n (%) | 26 (13.1%) |
Histopathology | |
Serous adenocarcinoma, n (%) | 163 (82.3%) |
Mucinous adenocarcinoma, n (%) | 11 (5.6%) |
Endometrioid adenocarcinoma, n (%) | 15 (7.6%) |
Clear Cell carcinoma, n (%) | 9 (4.5%) |